Simultaneous inhibition of PD-1 and LAG-3: the future of immunotherapy?
Sign Up to like & getrecommendations! Published in 2023 at "Immunotherapy"
DOI: 10.2217/imt-2022-0185
Abstract: Immunotherapy has improved the prognosis of many cancers, yet a large number of patients have demonstrated resistance to current immune checkpoint inhibitors. LAG-3 is an immune checkpoint expressed on tumor-infiltrating lymphocytes CD4+ and CD8+, Tregs… read more here.
Keywords: lag; immune checkpoint; immunotherapy; immunotherapy simultaneous ... See more keywords